Search bioRxiv⌕ Search

bioRxiv · 10.1101/2022.12.12.520146

Genetic Substrates of Brain Vulnerability and Resilience in APOE2 Mice Transitioning from Midlife to Old Age

Abstract

Understanding the interplay between genotype, age, and sex has potential to reveal factors that determine the switch between successful and pathological aging. APOE allelic variation modulate brain vulnerability and cognitive resilience during aging and Alzheimer disease (AD). The APOE4 allele confers the most risk and has been extensively studied with respect to the control APOE3 allele. The APOE2 allele has been less studied, and the mechanisms by which it confers cognitive resilience and neuroprotection remain largely unknown. Using mouse models with targeted replacement of the murine APOE gene with the human major APOE2 alleles we sought to identify changes during a critical period of middle to old age transition, in a mouse model of resilience to AD. Age but not female sex was important in modulating learning and memory estimates based on Morris water maze metrics. A small but significant 3% global brain atrophy due to aging was reflected by regional atrophy in the cingulate cortex 24, fornix and hippocampal commissure (>9%). Females had larger regional volumes relative to males for the bed nucleus of stria terminalis, subbrachial nucleus, postsubiculum (~10%), and claustrum (>5%), while males had larger volumes for the orbitofrontal cortex, frontal association cortex, and the longitudinal fasciculus of pons (>9%). Age promoted atrophy in both white (anterior commissure, corpus callosum, etc.), and gray matter, in particular the olfactory cortex, frontal association area 3, thalamus, hippocampus and cerebellum. A negative age by sex interaction was noted for the olfactory areas, piriform cortex, amygdala, ventral hippocampus, entorhinal cortex, and cerebellum, suggesting faster decline in females. Fractional anisotropy indicated an advantage for younger females for the cingulate cortex, insula, dorsal thalamus, ventral hippocampus, amygdala, visual and entorhinal cortex, and cerebellum, but there was faster decline with age. Interestingly white matter tracts were largely spared in females during aging. We used vertex screening to find associations between connectome and traits such as age and sex, and sparse multiple canonical correlation analysis to integrate our analyses over connectomes, traits, and RNA-seq. Brain subgraphs favored in males included the secondary motor cortex and superior cerebellar peduncle, while those for females included hippocampus and primary somatosensory cortex. Age related connectivity loss affected the hippocampus and primary somatosensory cortex. We validated these subgraphs using neural networks, showing increased accuracy for sex prediction from 81.9% when using the whole connectome as a predictor, to 94.28% when using the subgraphs estimated through vertex screening. Transcriptomic analyses revealed the largest fold change (FC) for age related genes was for Cpt1c (log2FC = 7.1), involved in transport of long-chain fatty acids into mitochondria and neuronal oxidative metabolism. Arg1, a critical regulator of innate and adaptive immune responses (log2FC = 4.9) also showed age specific changes. Amongst the sex related genes, the largest FC were observed for Maoa (log2FC = 4.9) involved in the degradation of the neurotransmitters serotonin, epinephrine, norepinephrine, and dopamine, and implicated in response to stress. Four genes were common for age and sex related vulnerability: Myo1e (log2FC = -1.5), Creld2 (log2FC = 1.4), Ptprt (log2FC = 2.9), and Pex1 (log2FC = 3.6). We tested whether blood gene expression help track phenotype changes with age and sex. Genes with the highest weight after connectome filtering included Ankzfp1 with a role in maintaining mitochondrial integrity under stress, as well as Pex1, Cep250, Nat14, Arg1, and Rangrf. Connectome filtered genes pointed to pathways relate to stress response, transport, and metabolic processes. Our modeling approaches using sparse canonical correlation analysis help relate quantitative traits to vulnerable brain networks, and blood markers for biological processes. Our study shows the APOE2 impact on neurocognition, brain networks, and biological pathways during a critical middle to old age transition in an animal model of resilience. Identifying changes in vulnerable brain and gene networks and markers of resilience may help reveal targets for therapies that support successful aging.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Mahzarnia, A., Moon, H. S., Stout, J. A., Anderson, R. J., Strain, M., Tremblay, J. T., Han, Z. Y., Niculescu, A. R., MacFarlane, A., King, J., Ashley-Koch, A., Clark, D. P., Lutz, M. W., Badea, A.. 2022-12-13. Genetic Substrates of Brain Vulnerability and Resilience in APOE2 Mice Transitioning from Midlife to Old Age. https://doi.org/10.1101/2022.12.12.520146

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗